Engineering strain for synthesizing pyridoxal phosphate and application
By constructing a Bacillus lichenli engineered strain that efficiently produces PLP, the problems of safety risks and high costs in the existing PLP synthesis methods are solved, and green and environmentally friendly and efficient production is achieved, which significantly improves the synthesis ability of PLP.
Patent Information
- Application Number
- CN202411195891.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-29
AI Technical Summary
In the existing PLP synthesis methods, chemical synthesis has safety risks and high cost problems, while the low catalytic efficiency and strict regulation of microbial synthesis limit the realization of high yields.
By knocking out the gene YwjH, the promoter of the PLP synthase gene pdxST was replaced as PxylA, and the gene xylR, overexpressing genes Zwf, GndA, YwlF, FbaA, and Tkt were introduced to construct a Bacillus lichenli engineered strain that efficiently produces PLP.
It significantly improves the synthesis capacity of PLP, achieves green and environmentally friendly and efficient production, is low-priced, and is suitable for large-scale industrial production.
Smart Images

Figure CN119040235A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of pyridoxal phosphate, and in particular to an engineering strain for synthesizing pyridoxal phosphate and its application. Background Art
[0002] Vitamin B6 is one of the essential vitamins for animals, plants and microorganisms, and is also a very important drug or food additive. Pyridoxal-5'-phosphate (PLP) is the only metabolically active form of vitamin B6 as a coenzyme, and is a coenzyme for more than 160 enzymes. PLP can be used as a scavenger of reactive oxygen species, a metal chelator, a molecular chaperone in the enzyme folding process, and a potential fungal antioxidant. It can also control the expression and action of steroid hormone receptors and may have a positive effect on immune function. It has high commercial value in medical, food industry, animal husbandry and agricultural production, and has a large market demand.
[0003] At present, the synthesis methods of PLP mainly include chemical synthesis and microbial synthesis. Chemical synthesis methods are generally limited by many problems such as the difficulty in handling industrial by-products, high production costs, and safety risks caused by high temperatures and chlorination reactions. Microbial methods are green and sustainable, but the low catalytic efficiency and strict regulation of general synthetic pathways will also limit the high yield of PLP. Summary of the invention
[0004] The inventors of this application creatively used Bacillus as a microbial chassis cell, and obtained a strain of Bacillus licheniformis that efficiently produces PLP by knocking out the gene YwjH and endowing the PLP synthase gene pdxST with a xylose-inducible promoter PxylA. The strain's ability to synthesize PLP is greatly improved, and it can provide extensive application support for the synthesis of PLP and VB6.
[0005] To this end, the embodiments of the present application disclose at least the following technical solutions:
[0006] In the first aspect, the embodiment discloses an engineered strain. The engineered strain is Bacillus licheniformis 9945a in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, GndA, YwlF, FbaA, and Tkt is overexpressed.
[0007] In the second aspect, the embodiment discloses an engineered strain. The engineered strain is Bacillus subtilis 168 in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, overexpressed gene GndA, overexpressed gene YwlF, overexpressed gene FbaA, and overexpressed gene Tkt is introduced.
[0008] In a third aspect, the embodiment discloses an engineered strain. The engineered strain is Bacillus licheniformis LL3 in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, GndA, YwlF, FbaA, and Tkt is overexpressed.
[0009] In a fourth aspect, the embodiments disclose an engineered strain, which is Bacillus licheniformis 9945a in which the gene YwjH is knocked out.
[0010] In a fifth aspect, the embodiment discloses an engineered strain in which the gene YwjH is knocked out and the promoter of the PLP synthase gene pdxST is replaced by the promoter P xylA of Bacillus licheniformis 9945a.
[0011] In a sixth aspect, the embodiment discloses an engineered strain, wherein the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter P xylA and Bacillus licheniformis 9945a with the xylR gene introduced.
[0012] In a seventh aspect, the embodiment discloses an engineered strain, wherein the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter P xylA , Bacillus licheniformis 9945a with introduced gene xylR, overexpressed gene Zwf, overexpressed gene GndA, overexpressed gene YwlF, overexpressed gene FbaA and overexpressed gene Tkt.
[0013] In an eighth aspect, the embodiment discloses a method for preparing an engineered strain. The engineered strain is a starting strain in which the gene YwjH is knocked out and the promoter of the PLP synthase gene pdxST is replaced by the promoter P xylA , a strain having at least one of the following introduced genes: xylR, overexpressed gene Zwf, overexpressed gene GndA, overexpressed gene YwlF, overexpressed gene FbaA, and overexpressed gene Tkt.
[0014] The preparation method comprises: obtaining a starting strain; obtaining a first plasmid, a second plasmid, a third plasmid and a fourth plasmid, wherein the first plasmid is used to knock out the gene YwjH, the second plasmid is used to replace the promoter of the PLP synthase gene pdxST with the promoter PxylA, the third plasmid is used to introduce the gene xylR, and the fourth plasmid is used to replace the promoter of any one of the genes Zwf, GndA, YwlF, FbaA and Tkt with P bacAU12 ; Transfer at least one of the first plasmid, the second plasmid, the third plasmid and the fourth plasmid into the starting strain.
[0015] In the ninth aspect, the embodiment discloses a method for synthesizing PLP, which comprises the step of fermenting the engineered strain described in any one of the first to seventh aspects.
[0016] In the tenth aspect, the embodiments disclose the use of the engineered strain described in any one of the first to seventh aspects in the synthesis of PLP. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] Figure 1 The content of pyridoxal phosphate in the fermentation products of the wild strain P0 and the engineered strains P1 to P8 provided in the examples.
[0018] Figure 2 OD of the fed-batch fermentation of the engineered strain P8 provided in the example 600 , residual sugar, PL and PLP curves. DETAILED DESCRIPTION
[0019] In order to make the purpose, technical scheme and advantages of the present application clearer, the present application is further described in detail below in conjunction with the examples. It should be understood that the specific embodiments described herein are only used to explain the present application and are not intended to limit the present application. The reagents not described separately in detail in the present application are all conventional reagents and can be obtained from commercial channels; the methods not described in detail are all conventional experimental methods and can be obtained from the prior art.
[0020] Bacillus licheniformis, Bacillus amyloliquefaciens and Bacillus subtilis all have the characteristics of biosafety, rapid growth, simple genetic manipulation and strong stress resistance, making them excellent microbial chassis cell factories to produce a variety of important biochemical substances. In this application, Bacillus licheniformis, Bacillus amyloliquefaciens and Bacillus subtilis are used as microbial chassis cells, and an engineered strain capable of synthesizing PLP and VB6 is constructed through basic engineering means. The engineered strain can synthesize PLP using glucose and yeast powder. The synthetic raw materials are green and environmentally friendly, low in price, and the synthesis level is significantly higher than that of wild strains. The genetically engineered strain provides a green manufacturing method for producing PLP at a high level using a cheap culture medium, which is suitable for large-scale industrial production of protocatechuic acid.
[0021] On the one hand, the embodiment discloses an engineered strain. The engineered strain is a strain in which the gene YwjH of the starting strain is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, overexpressed gene GndA, overexpressed gene YwlF, overexpressed gene FbaA, and overexpressed gene Tkt is introduced.
[0022] In some embodiments, the starting strain is Bacillus licheniformis 9945a and its accession number is CCTCCM2011344.
[0023] In some embodiments, the starting strain is Bacillus subtilis BS168.
[0024] In some embodiments, the starting strain is Bacillus amyloliquefaciens LL3.
[0025] Knockout gene YwjH
[0026] In one aspect, the embodiment discloses a first plasmid. The first plasmid carries a first donor plasmid consisting of an upstream homology arm and a downstream homology arm of gene YwjH.
[0027] In one aspect, the embodiment discloses an engineered strain. The engineered strain is a strain in which the gene YwjH of the starting strain is knocked out.
[0028] In some embodiments, the gene YwjH of Bacillus paralicheniformis ATCC 9945a is located at 3963999..3964634 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c39750.
[0029] In some embodiments, the gene YwjH of Bacillus subtilis subsp. subtilisstr.168 is located at 3807767..3808405 of NCBI accession number GenBank: CP010052.1, and the site name is QU35_20085.
[0030] In some embodiments, the gene YwjH of Bacillus amyloliquefaciens LL3 is located at 3616186..3616824 of NCBI accession number GenBank: CP002634.1, and the site name is LL3_03859.
[0031] On the one hand, the embodiment discloses a method for preparing the engineered strain. The method comprises:
[0032] 1. Obtaining the first donor
[0033] The upstream homology arm (SEQ ID NO: 1) of the gene YwjH of Bacillus licheniformis 9945a and the downstream homology arm (SEQ ID NO: 2) of the gene YwjH of Bacillus licheniformis 9945a were amplified by PCR from the genomic DNA of Bacillus licheniformis 9945a. The upstream homology arm and the downstream homology arm were connected by overlap extension PCR to obtain the first donor shown in SEQ ID NO: 3, which was used to replace the gene YwjH of Bacillus licheniformis 9945a.
[0034] The upstream homology arm (SEQ ID NO: 4) of the gene YwjH of Bacillus licheniformis BS168 and the downstream homology arm (SEQ ID NO: 5) of the gene YwjH of Bacillus licheniformis BS168 were amplified by PCR from the genomic DNA of Bacillus licheniformis BS168. By overlapping extension PCR, the upstream homology arm and the downstream homology arm were connected to obtain the first donor shown in SEQ ID NO: 6, which was used to replace the gene YwjH of Bacillus subtilis BS168.
[0035] The upstream homology arm (SEQ ID NO: 7) of the gene YwjH of Bacillus amyloliquefaciens LL3 and the downstream homology arm (SEQ ID NO: 8) of the gene YwjH of Bacillus amyloliquefaciens LL3 were amplified by PCR from the genomic DNA of Bacillus amyloliquefaciens LL3. The upstream homology arm and the downstream homology arm were connected by overlap extension PCR to obtain the first donor shown in SEQ ID NO: 9, which was used to replace the gene YwjH of Bacillus amyloliquefaciens LL3.
[0036] 2. Preparation of the first plasmid
[0037] The first donor as shown in SEQ ID NO: 3, SEQ ID NO: 6 or SEQ ID NO: 9 was double-digested with Bam HI (Beijing Quanshijin Biotechnology) and Sac I (Beijing Quanshijin Biotechnology), and the plasmid T2 was double-digested with Bam HI and Sac I to obtain linear T2 (SEQ ID NO: 10).
[0038] The enzyme fragments of the first donor were connected to the linear T2 by T4 DNA ligase, and the ligation products were transformed into Escherichia coli DH5α, and positive clones were screened by kanamycin resistance and colony PCR, and the first plasmid was extracted from the positive clones. The primer pair used in colony PCR was T2-F (SEQ ID NO: 11) and T2-R (SEQ ID NO: 12).
[0039] 3. Preparation of YwjH gene knockout engineered strain
[0040] The first plasmid was transferred into the starting strain, and an engineering strain with YwjH gene knockout was obtained through screening.
[0041] In some embodiments, the first plasmid carrying the first donor as shown in SEQ ID NO:3 is transferred into Bacillus licheniformis 9945a, and positive clones are screened by kanamycin resistance and colony PCR. The primers are YwjH (9945a) -YF (such as SEQ ID NO: 13) and YwjH (9945a) -YR (such as SEQ ID NO: 14). If the colony PCR amplification product is subjected to electrophoresis detection and a 1035 bp electrophoresis band appears, it is proved that the YwjH gene knockout engineered strain P1 is obtained.
[0042] In some embodiments, the first plasmid carrying the first donor as shown in SEQ ID NO:6 is transferred into Bacillus subtilis BS168, and positive clones are screened by kanamycin resistance and colony PCR. The primers are YwjH(168)-YF (such as SEQ ID NO:15) and YwjH(168)-YR (such as SEQ ID NO:16). If the colony PCR amplification product is subjected to electrophoresis detection and a 1012 bp electrophoresis band appears, it is proved that the YwjH gene knockout engineered strain 168△YwjH is obtained.
[0043] In some embodiments, the first plasmid carrying the first donor as shown in SEQ ID NO:9 is transferred into Bacillus amyloliquefaciens LL3, and positive clones are screened by kanamycin resistance and colony PCR. Wherein, the primers are YwjH (LL3) -YF (such as SEQ ID NO:17) and YwjH (LL3) -YR (such as SEQ ID NO:18). If the colony PCR amplification product is subjected to electrophoresis detection and a 1054 bp electrophoresis band appears, it is proved that the YwjH gene knockout engineered strain LL3△YwjH is obtained.
[0044] Replace the promoter of the PLP synthase gene pdxST with the promoter PxylA
[0045] In one aspect, the embodiment discloses a second plasmid carrying a second donor plasmid consisting of an upstream homology arm of the promoter of the gene pdxST, a promoter PxylA, and a downstream homology arm of the promoter of the gene pdxST.
[0046] In one aspect, the embodiment discloses an engineered strain, wherein the gene YwjH of the starting strain is knocked out and the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA (SEQ ID NO: 19).
[0047] In some embodiments, the promoter of pdxST of Bacillus licheniformis 9945a is located at 18695..19579 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c00160.
[0048] On the one hand, the embodiment discloses a method for preparing the engineered strain. The method comprises:
[0049] 1. Obtaining a second donor
[0050] The upstream homology arm (SEQ ID NO: 20) and the downstream homology arm (SEQ ID NO: 21) of the PLP gene pdxS promoter of Bacillus licheniformis 9945a were amplified by PCR from the genomic DNA of Bacillus licheniformis 9945a.
[0051] By overlapping extension PCR, the upstream homology arm of the pdxS promoter, the PxylA promoter (SEQ ID NO: 19) and the downstream homology arm of the pdxS promoter were connected to obtain a second donor (such as SEQ ID NO: 22).
[0052] 2. Second plasmid
[0053] The second donor was double-digested with BamHI and SacI restriction endonucleases, and the plasmid T2 was double-digested with BamHI and SacI restriction endonucleases to obtain linear T2. The digested fragment of the second donor was connected with the linear T2 by T4 DNA ligase, and the ligation product was transformed into Escherichia coli DH5α. The positive clones were screened by kanamycin resistance and colony PCR, and the second plasmid was extracted from the positive clones. The primer pair used in colony PCR was T2-F and T2-R.
[0054] 3. Preparation of engineered strain P2
[0055] The second plasmid was transferred into the engineering strain 9945a△YwjH, and positive clones were obtained by karanomycin plate and colony PCR screening. Among them, the colony PCR verification primers were pdxS-F2 (SEQ ID NO: 23) and pdxS-YR (SEQ ID NO: 24). If the colony PCR amplification product was subjected to electrophoresis detection and an electrophoresis band appeared at 1024bp, it indicated that the promoter of pdxS was successfully replaced in Bacillus licheniformis P1, and after successful sequencing, the engineering strain P2 was obtained.
[0056] Introduction of xylR gene
[0057] In one aspect, the embodiment discloses a third plasmid. The third plasmid is a plasmid carrying a third donor consisting of an upstream homology arm of the amyL gene of Bacillus licheniformis 9945a, a PbacAU12 promoter, a xylR gene, and an upstream homology arm of the amyL gene of Bacillus licheniformis 9945a.
[0058] In one aspect, the embodiment discloses an engineered strain, wherein the gene YwjH of Bacillus licheniformis 9945a is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, and the gene xylR is introduced.
[0059] On the one hand, the embodiment discloses a method for preparing the engineered strain. The method comprises:
[0060] 1. Preparation of the third donor
[0061] The upstream homology arm of the amyL gene of Bacillus licheniformis 9945a (SEQ ID NO: 25), the upstream homology arm of the amyL gene (SEQ ID NO: 26) and the xylR gene (SEQ ID NO: 27) were obtained by PCR amplification from the genomic DNA of Bacillus licheniformis 9945a. Among them, the amyL gene is located at 723302..724840 of NCBI number GenBank: CP005965.1, and the site name is BaLi_c07450.
[0062] The PbacAU12 promoter (SEQ ID NO: 30) was PCR amplified using PbacAU12-F (SEQ ID NO: 28) and PbacAU12-R (SEQ ID NO: 29) as a primer pair.
[0063] By overlap extension PCR, the upstream homology arm of the amyL gene, the PbacAU12 promoter, the xylR gene and the downstream homology arm of the amyL gene were sequentially connected to obtain a third donor (SEQ ID NO: 31).
[0064] 2. Preparation of the third plasmid
[0065] The second donor was double-digested with BamHI and SacI restriction endonucleases, and the plasmid T2 was double-digested with BamHI and SacI restriction endonucleases to obtain linear T2. The restriction fragment of the third donor was connected with the linear T2 by T4 DNA ligase, and the connection product was transformed into Escherichia coli DH5α. The positive clones were screened by kanamycin resistance and colony PCR, and the third plasmid was extracted from the positive clones. The primer pair used in colony PCR was T2-F and T2-R.
[0066] 3. Preparation of engineered strain P3
[0067] The third plasmid was transferred into the engineered strain P2, and positive clones were obtained by karanomycin plate and colony PCR screening. Among them, the colony PCR verification primers were PbacAU12xylR-YF (SEQ ID NO: 32) and PbacAU12xylR-YR (SEQ ID NO: 33). If the colony PCR amplification product was subjected to electrophoresis detection and an electrophoresis band appeared at 2889 bp, it indicated that the promoter of pdxS was successfully replaced in Bacillus licheniformis P1, and after successful sequencing, the engineered strain P3 was obtained.
[0068] Promoter replacement of Zwf, GndA, YwlF, FbaA and Tkt genes
[0069] On the one hand, the embodiment provides a fourth plasmid. The fourth plasmid is a plasmid carrying a fourth donor consisting of an upstream homology arm of any Zwf, GndA, YwlF, FbaA or Tkt gene, a PbacAU12 promoter and a downstream homology arm of any Zwf, GndA, YwlF, FbaA or Tkt gene.
[0070] On the one hand, the embodiment discloses an engineered strain. The engineered strain Bacillus licheniformis 9945a has its gene YwjH knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and the genes Zwf, GndA, YwlF, FbaA, and Tkt are overexpressed.
[0071] In some embodiments, the gene Zwf of Bacillus licheniformis 9945a is located at 2634624..2636087 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c26410.
[0072] In some embodiments, the gene GndA of Bacillus licheniformis 9945a is located at 2647052..2648461 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c26520.
[0073] In some embodiments, the gene YwlF of Bacillus licheniformis 9945a is located at 3941385..3941834 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c39520.
[0074] In some embodiments, the gene FbaA of Bacillus licheniformis 9945a is located at 3964864..3965721 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c39760.
[0075] In some embodiments, the gene Tkt of Bacillus licheniformis 9945a is located at 2035586..2037589 of NCBI accession number GenBank: CP005965.1, and the site name is BaLi_c21020.
[0076] On the one hand, the embodiment discloses a method for preparing the engineered strain. The method comprises:
[0077] 1. Preparation of the fourth donor
[0078] The upstream homology arm of the Zwf gene (SEQ ID NO: 34) and the downstream homology arm of the Zwf gene (SEQ ID NO: 35) were obtained by PCR amplification from the genomic DNA of Bacillus licheniformis 9945a. PbacAU12-F and PbacAU12-R were used as primers to PCR amplify the PbacAU12 promoter. By overlapping extension PCR, the upstream homology arm of the Zwf gene, the PbacAU12 promoter (SEQ ID NO: 30) and the downstream homology arm of the Zwf gene were sequentially connected to obtain the fourth donor (SEQ ID NO: 36) for replacing the Zwf gene promoter.
[0079] The upstream homology arm of the GndA gene (SEQ ID NO: 37) and the downstream homology arm of the GndA gene (SEQ ID NO: 38) were amplified from the genomic DNA of Bacillus licheniformis 9945a by PCR. By overlapping extension PCR, the upstream homology arm of the GndA gene, the PbacAU12 promoter (SEQ ID NO: 30) and the downstream homology arm of the GndA gene were sequentially connected to obtain the fourth donor (SEQ ID NO: 39) for replacing the GndA gene promoter.
[0080] The upstream homology arm of the YwlF gene (SEQ ID NO: 40) and the downstream homology arm of the YwlF gene (SEQ ID NO: 41) were amplified from the genomic DNA of Bacillus licheniformis 9945a by PCR. The upstream homology arm of the YwlF gene, the PbacAU12 promoter (SEQ ID NO: 30) and the downstream homology arm of the YwlF gene were sequentially connected by overlap extension PCR to obtain the fourth donor (SEQ ID NO: 42) for replacing the YwlF gene promoter.
[0081] The upstream homology arm of the FbaA gene (SEQ ID NO: 43) and the downstream homology arm of the FbaA gene (SEQ ID NO: 44) were amplified from the genomic DNA of Bacillus licheniformis 9945a by PCR. The upstream homology arm of the FbaA gene, the PbacAU12 promoter (SEQ ID NO: 30) and the downstream homology arm of the FbaA gene were sequentially connected by overlap extension PCR to obtain a fourth donor (SEQ ID NO: 45) for replacing the FbaA gene promoter.
[0082] The upstream homology arm of the Tkt gene (SEQ ID NO: 46) and the downstream homology arm of the Tkt gene (SEQ ID NO: 47) were amplified from the genomic DNA of Bacillus licheniformis 9945a by PCR. By overlapping extension PCR, the upstream homology arm of the Tkt gene, the PbacAU12 promoter (SEQ ID NO: 30) and the downstream homology arm of the Tkt gene were sequentially connected to obtain the fourth donor (SEQ ID NO: 48) for replacing the Tkt gene promoter.
[0083] 2. Preparation of the fourth plasmid
[0084] The fourth donor was double-digested with Bam HI and Sac I, respectively, and ligated with the double-digested fragment of the T2 plasmid using T4 DNA ligase. The ligation product was transformed into Escherichia coli DH5α, and positive clones were obtained by plate screening and colony PCR verification. The fourth plasmids carrying the fourth donor shown in SEQ ID NO: 36, SEQ ID NO: 39, SEQ ID NO: 42, SEQ ID NO: 45 or SEQ ID NO: 48 were extracted from the positive clones.
[0085] 3. Preparation of engineered strains
[0086] The fourth donor carrying the promoter for replacing the Zwf gene was transferred into the engineering strain P3. After plate screening and strain PCR verification, the positive clone obtained was the strain in which the Zwf gene promoter was replaced by the PbacAU12 promoter, and was named engineering strain P4.
[0087] The fourth donor carrying the promoter for replacing the GndA gene was transferred into the engineering strain P4. After plate screening and strain PCR verification, the positive clone obtained was the strain in which the GndA gene promoter was replaced by the PbacAU12 promoter, and was named the engineering strain P5.
[0088] The fourth donor carrying the promoter for replacing the YwlF gene was transferred into the engineering strain P5. After plate screening and strain PCR verification, the positive clone obtained was the strain in which the YwlF gene promoter was replaced by the PbacAU12 promoter, and was named engineering strain P6.
[0089] The fourth donor carrying the promoter for replacing the FbaA gene was transferred into the engineering strain P6. After plate screening and strain PCR verification, the positive clone obtained was the strain in which the FbaA gene promoter was replaced by the PbacAU12 promoter, and was named engineering strain P7.
[0090] The fourth donor carrying the promoter for replacing the Tkt gene was transferred into the engineering strain P7. After plate screening and strain PCR verification, the positive clone obtained was the strain in which the Tkt gene promoter was replaced by the PbacAU12 promoter, and was named the engineering strain P8.
[0091] Fermentation tests of different engineered strains
[0092] The engineered strains P1-P8, engineered strain 168ΔYwjH, engineered strain LL3ΔYwjH, Bacillus licheniformis 9945a, Bacillus subtilis BS168 and Bacillus amyloliquefaciens LL3 obtained in the above examples were subjected to fermentation tests to test their ability to produce pyridoxal phosphate.
[0093] 1. Fermentation test of engineered strain P1, engineered strain 168△YwjH, engineered strain LL3△YwjH and wild strain
[0094] The test strains were activated on the plates, and the strains were inoculated into 250 mL Erlenmeyer flasks containing 30 mL of liquid LB, and cultured at 37°C and 230 rpm for 12 h. Then, they were inoculated into different fermentation media (as shown in Table 1) at an inoculum of 3% (volume ratio). The pyridoxal phosphate fermentation medium was: 60-100 g / L of glucose, 10-20 g / L of yeast powder, 1-5 g / L of trisodium citrate, 10-30.0 g / L of (NH4)2SO4, 1-5 g / L of KH2PO4, 1-5 g / L of MgSO4·7H2O, and 1-10 mg / L of MnSO4·5H2O. Cultured at 37°C and 230 rpm for 24-72 h, the pyridoxal phosphate yield was determined after the fermentation was completed. The yields of pyridoxal phosphate obtained by different fermentation medium formulas are shown in Table 2. In Table 2, the yield increase percentage (%) is calculated as: (pyridoxal phosphate yield of the knockout strain-pyridoxal phosphate yield of the control strain) / pyridoxal phosphate yield of the control strain×100%.
[0095] Table 1 Culture medium formula
[0096]
[0097] Table 2
[0098]
[0099] 2. Fermentation test of Bacillus licheniformis 9945a (P0), P1~P8
[0100] Bacillus licheniformis 9945a (P0), P1-P8 were activated on the plate, and the bacteria were inoculated into 250mL Erlenmeyer flasks containing 30mL liquid LB, and cultured at 37°C and 230rpm for 12h. Then, the inoculum was inoculated into the fermentation medium at a volume ratio of 3%, and the fermentation was carried out at 37°C and 230rpm for 24-72h to determine the yield of pyridoxal phosphate. The fermentation medium contained: 80g / L glucose, 15g / L yeast powder, 2g / L trisodium citrate, 20g / L (NH4)2SO4, 2g / L KH2PO4, 3g / L MgSO4·7H2O, and 5.0mg / L MnSO4·5H2O.
[0101] The results show that ( Figure 1 ), the control strain 9945a (P0) could synthesize 66.52 mg / L of pyridoxal phosphate, and after superposition and enhancement of multiple genes, the engineered strain P8 was obtained, and the pyridoxal phosphate production could reach 673.85 mg / L, which is the highest level of de novo synthesis reported in shake flasks.
[0102] 3. Fed-batch fermentation test of engineered strain P8
[0103] The formula of the 5L fermentation tank culture medium is: glucose 80g / L, yeast powder 15g / L, trisodium citrate 2g / L, (NH4)2SO420 g / L, KH2PO42 g / L, MgSO4·7H2O 3g / L, MnSO4·5H2O 5.0mg / L; the total volume of the liquid culture medium is 2L. The strain of the best engineering bacteria P8 is streaked and activated on LB solid culture medium, and inverted and cultured at 37°C for 20-24h; the colony on the plate is picked and inoculated into 50mL LB liquid culture medium for activation, and cultured at 230rpm / min and 37°C for 10-12h to obtain seed liquid (OD6004-5); the inoculation amount of the seed liquid inoculated into the 5L fermentation tank is 10% (200mL), and the initial pH value is 7.0.
[0104] like Figure 2 As shown in the figure, the fermentation time was 72h, the strain biomass reached a maximum of 67.68 at 36h, and continued to decline after 36h, with the end point biomass OD600 of 37.4. The PLP yield continued to increase, reaching a maximum of 1.51g / L at 72h, which was 22.35 times higher than the PLP yield of the starting strain 9945a, and is the highest fermentation level of PLP de novo synthesis reported so far.
[0105] The above is only a preferred specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily conceived by any technician familiar with the technical field within the technical scope disclosed in the present application should be covered within the protection scope of the present application.
Claims
1. An engineered strain, which is Bacillus licheniformis 9945a, in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, GndA, YwlF, FbaA, and Tkt is overexpressed.
2. An engineered strain, which is Bacillus subtilis 168 in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter PxylA, the gene xylR is introduced, and at least one of the genes Zwf, GndA, YwlF, FbaA and Tkt is overexpressed.
3. An engineered strain, which is Bacillus licheniformis LL3 in which gene YwjH is knocked out, the promoter of PLP synthase gene pdxST is replaced by promoter PxylA, gene xylR is introduced, and at least one of gene Zwf, gene GndA, gene YwlF, gene FbaA, and gene Tkt is overexpressed.
4. An engineered strain, which is Bacillus licheniformis 9945a with gene YwjH knocked out.
5. An engineered strain, which is Bacillus licheniformis 9945a in which the gene YwjH is knocked out and the promoter of the PLP synthase gene pdxST is replaced by the promoter PxylA.
6. An engineered strain, which is Bacillus licheniformis 9945a in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter PxylA, and the gene xylR is introduced.
7. An engineered strain, which is Bacillus licheniformis 9945a in which the gene YwjH is knocked out, the promoter of the PLP synthase gene pdxST is replaced by the promoter PxylA, the gene xylR is introduced, and the genes Zwf, GndA, YwlF, FbaA and Tkt are overexpressed.
8. A method for preparing an engineered strain, wherein the engineered strain is a strain in which the gene YwjH of the starting strain is knocked out, the promoter of the PLP synthase gene pdxST is replaced with the promoter PxylA, the gene xylR is introduced, and at least one of the overexpressed genes Zwf, overexpressed gene GndA, overexpressed gene YwlF, overexpressed gene FbaA, and overexpressed gene Tkt is introduced; The preparation method comprises: Obtain the starting strain; Obtain a first plasmid, a second plasmid, a third plasmid, a fourth plasmid and a fifth plasmid, wherein the first plasmid is used to knock out the gene YwjH, the second plasmid is used to replace the promoter of the PLP synthase gene pdxST with the promoter PxylA, the third plasmid is used to introduce the gene xylR, and the fourth plasmid is used to replace the promoter of any one of the genes Zwf, GndA, YwlF, FbaA and Tkt with PbacAU12; at least one of the first plasmid, the second plasmid, the third plasmid and the fourth plasmid is transferred into the starting strain.
9. A method for synthesizing PLP, comprising the step of fermenting the engineered strain according to any one of claims 1 to 7.
10. Use of the engineered strain according to any one of claims 1 to 7 in synthesizing PLP.
Citation Information
Cited By
Engineered strain for high-yield of l-theanine, construction method and application thereof
CN122898437A
